1. Home
  2. SDOT vs ACXP Comparison

SDOT vs ACXP Comparison

Compare SDOT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sadot Group Inc.

SDOT

Sadot Group Inc.

HOLD

Current Price

$3.26

Market Cap

7.6M

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$3.34

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDOT
ACXP
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SDOT
ACXP
Price
$3.26
$3.34
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$143.67
AVG Volume (30 Days)
53.0K
51.9K
Earning Date
11-19-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,078,000.00
N/A
Revenue This Year
$12.76
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.43
$3.17
52 Week High
$43.90
$25.00

Technical Indicators

Market Signals
Indicator
SDOT
ACXP
Relative Strength Index (RSI) 38.35 34.59
Support Level $2.74 $3.17
Resistance Level $3.37 $4.48
Average True Range (ATR) 0.37 0.36
MACD 0.01 -0.07
Stochastic Oscillator 30.15 15.54

Price Performance

Historical Comparison
SDOT
ACXP

About SDOT Sadot Group Inc.

Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: